Tianxia Li

1.1k total citations
12 papers, 141 citations indexed

About

Tianxia Li is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Genetics. According to data from OpenAlex, Tianxia Li has authored 12 papers receiving a total of 141 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 3 papers in Pulmonary and Respiratory Medicine and 3 papers in Genetics. Recurrent topics in Tianxia Li's work include Genomic variations and chromosomal abnormalities (2 papers), PI3K/AKT/mTOR signaling in cancer (2 papers) and Genetics and Neurodevelopmental Disorders (2 papers). Tianxia Li is often cited by papers focused on Genomic variations and chromosomal abnormalities (2 papers), PI3K/AKT/mTOR signaling in cancer (2 papers) and Genetics and Neurodevelopmental Disorders (2 papers). Tianxia Li collaborates with scholars based in China, United States and Denmark. Tianxia Li's co-authors include Juntian Liu, Yuanhui Zhang, Zengdun Shi, Don C. Rockey, Adam J. Bass, Aaron R. Thorner, Peter S. Hammerman, Changhong Miao, Pranshu Sahgal and Wankun Chen and has published in prestigious journals such as Journal of Clinical Oncology, Gut and Clinical Cancer Research.

In The Last Decade

Tianxia Li

11 papers receiving 139 citations

Peers

Tianxia Li
Elisa Brandt Germany
Tianxia Li
Citations per year, relative to Tianxia Li Tianxia Li (= 1×) peers Elisa Brandt

Countries citing papers authored by Tianxia Li

Since Specialization
Citations

This map shows the geographic impact of Tianxia Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tianxia Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tianxia Li more than expected).

Fields of papers citing papers by Tianxia Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tianxia Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tianxia Li. The network helps show where Tianxia Li may publish in the future.

Co-authorship network of co-authors of Tianxia Li

This figure shows the co-authorship network connecting the top 25 collaborators of Tianxia Li. A scholar is included among the top collaborators of Tianxia Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tianxia Li. Tianxia Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Li, Tianxia, et al.. (2025). A Mutation in the ANK2 Gene Causing ASD and a Review of the Literature. Molecular Genetics & Genomic Medicine. 13(3). e70083–e70083.
2.
Cohen, David, et al.. (2025). Sensitizing K-Ras G12D mutant colorectal patient-derived organoids via ferroptosis pathway.. Journal of Clinical Oncology. 43(4_suppl). 211–211. 1 indexed citations
3.
Li, Tianxia, Uma M. Sachdeva, Andres J. Klein–Szanto, et al.. (2024). Lactate Suppresses Growth of Esophageal Adenocarcinoma Patient-Derived Organoids through Alterations in Tumor NADH/NAD+ Redox State. Biomolecules. 14(9). 1195–1195. 1 indexed citations
4.
Sahu, Varun, Ke Peng, Tianxia Li, et al.. (2024). Recurrent RhoGAP gene fusion CLDN18-ARHGAP26 promotes RHOA activation and focal adhesion kinase and YAP-TEAD signalling in diffuse gastric cancer. Gut. 73(8). 1280–1291. 11 indexed citations
5.
Li, Tianxia, Osamu Kikuchi, Jin Zhou, et al.. (2023). Developing SHP2-based combination therapy for KRAS-amplified cancer. JCI Insight. 8(3). 7 indexed citations
6.
Peng, Ke, Pranshu Sahgal, Tianxia Li, et al.. (2022). Development of Combination Strategies for Focal Adhesion Kinase Inhibition in Diffuse Gastric Cancer. Clinical Cancer Research. 29(1). 197–208. 10 indexed citations
7.
Li, Qianqian, Lei Zhang, Yue Chen, et al.. (2022). Hypogyrification in Generalized Anxiety Disorder and Associated with Insomnia Symptoms. Nature and Science of Sleep. Volume 14. 1009–1019. 11 indexed citations
8.
Fu, Zhuo, et al.. (2021). Case Report: A Case Report and Literature Review of 3p Deletion Syndrome. Frontiers in Pediatrics. 9. 618059–618059. 8 indexed citations
9.
Fu, Zhuo, Tianxia Li, Jingjing Zhao, et al.. (2021). A case of 15q11‐q13 duplication syndrome and literature review. Brain and Behavior. 11(8). e2219–e2219. 1 indexed citations
10.
Bockorny, Bruno, Maria Rusan, Wankun Chen, et al.. (2018). RAS–MAPK Reactivation Facilitates Acquired Resistance in FGFR1 -Amplified Lung Cancer and Underlies a Rationale for Upfront FGFR–MEK Blockade. Molecular Cancer Therapeutics. 17(7). 1526–1539. 43 indexed citations
11.
Li, Tianxia, Zengdun Shi, & Don C. Rockey. (2012). Preproendothelin-1 expression is negatively regulated by IFNγ during hepatic stellate cell activation. American Journal of Physiology-Gastrointestinal and Liver Physiology. 302(9). G948–G957. 19 indexed citations
12.
Liu, Juntian, et al.. (2007). Protective Effect of Protopine on the Focal Cerebral Ischaemic Injury in Rats. Basic & Clinical Pharmacology & Toxicology. 101(2). 85–89. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026